Entrada Therapeutics Inc (TRDA) — Cash Flow Reinvestment Rate
Entrada Therapeutics Inc (TRDA) has a Cash Flow Reinvestment Rate of 0.64x as of June 2024, reinvesting $25.43 Million (capex $1.05 Million plus investments $-24.38 Million) from operating cash flow of $39.83 Million. Explore Entrada Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Entrada Therapeutics Inc Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Entrada Therapeutics Inc across 1 annual periods. Also explore TRDA total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Entrada Therapeutics Inc (2023–2023)
Year-by-year capital reinvestment analysis for Entrada Therapeutics Inc. For live market cap and broader valuation context, see market value of Entrada Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.03x | $144.26 Million | $139.80 Million | $5.61 Million | — |